A new cancer drug candidate developed by Lawrence Livermore National Laboratory (LLNL), BBOT (BridgeBio Oncology Therapeutics) and the Frederick National Laboratory for Cancer Research (FNLCR) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback